United States Nuclear Medicine & Radio Pharmaceuticals Market Report 2016

November 2016 | 101 pages | ID: U7A0A8CABA7EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Nuclear Medicine & Radio Pharmaceuticals

Revenue, means the sales value of Nuclear Medicine & Radio Pharmaceuticals

This report studies sales (consumption) of Nuclear Medicine & Radio Pharmaceuticals in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• GE Healthcare
• Philips Healthcare
• Siemens Healthcare
• Toshiba
• Hitachi
• Carestream
• Esaote
• Shimadzu
• TriFoil Imaging
• Biosensors International Group, Ltd.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
• Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals in each application, can be divided into

• Diagnostic Applications: SPECT, PET.
• Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
• Application 3

Contents

United States Nuclear Medicine & Radio Pharmaceuticals Market Report 2016

1 NUCLEAR MEDICINE & RADIO PHARMACEUTICALS OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine & Radio Pharmaceuticals
1.2 Classification of Nuclear Medicine & Radio Pharmaceuticals
  1.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.
  1.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes.
  1.2.3 Type III
1.3 Application of Nuclear Medicine & Radio Pharmaceuticals
  1.3.1 Diagnostic Applications: SPECT, PET.
  1.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Nuclear Medicine & Radio Pharmaceuticals (2011-2021)
  1.4.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2011-2021)
  1.4.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2011-2021)

2 UNITED STATES NUCLEAR MEDICINE & RADIO PHARMACEUTICALS COMPETITION BY MANUFACTURERS

2.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Nuclear Medicine & Radio Pharmaceuticals Average Price by Manufactures (2015 and 2016)
2.4 Nuclear Medicine & Radio Pharmaceuticals Market Competitive Situation and Trends
  2.4.1 Nuclear Medicine & Radio Pharmaceuticals Market Concentration Rate
  2.4.2 Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NUCLEAR MEDICINE & RADIO PHARMACEUTICALS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Type (2011-2016)
3.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Type (2011-2016)
3.3 United States Nuclear Medicine & Radio Pharmaceuticals Price by Type (2011-2016)
3.4 United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NUCLEAR MEDICINE & RADIO PHARMACEUTICALS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Application (2011-2016)
4.2 United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MANUFACTURERS PROFILES/ANALYSIS

5.1 GE Healthcare
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Philips Healthcare
  5.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Siemens Healthcare
  5.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Toshiba
  5.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Hitachi
  5.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Carestream
  5.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Esaote
  5.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Shimadzu
  5.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 TriFoil Imaging
  5.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Biosensors International Group, Ltd.
  5.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Biosensors International Group, Ltd. Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MANUFACTURING COST ANALYSIS

6.1 Nuclear Medicine & Radio Pharmaceuticals Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NUCLEAR MEDICINE & RADIO PHARMACEUTICALS MARKET FORECAST (2016-2021)

10.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue Forecast (2016-2021)
10.2 United States Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Type (2016-2021)
10.3 United States Nuclear Medicine & Radio Pharmaceuticals Sales Forecast by Application (2016-2021)
10.4 Nuclear Medicine & Radio Pharmaceuticals Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nuclear Medicine & Radio Pharmaceuticals
Table Classification of Nuclear Medicine & Radio Pharmaceuticals
Figure United States Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type in 2015
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes. Picture
Table Application of Nuclear Medicine & Radio Pharmaceuticals
Figure United States Sales Market Share of Nuclear Medicine & Radio Pharmaceuticals by Application in 2015
Figure Diagnostic Applications: SPECT, PET. Examples
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2011-2021)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2011-2021)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales of Key Manufacturers (2015 and 2016)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nuclear Medicine & Radio Pharmaceuticals Sales Share by Manufacturers
Figure 2016 Nuclear Medicine & Radio Pharmaceuticals Sales Share by Manufacturers
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue by Manufacturers (2015 and 2016)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers
Table 2016 United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers
Table United States Market Nuclear Medicine & Radio Pharmaceuticals Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nuclear Medicine & Radio Pharmaceuticals Average Price of Key Manufacturers in 2015
Figure Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 Manufacturers
Figure Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 5 Manufacturers
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales by Type (2011-2016)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Share by Type (2011-2016)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Type in 2015
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Type (2011-2016)
Table United States Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nuclear Medicine & Radio Pharmaceuticals by Type (2011-2016)
Table United States Nuclear Medicine & Radio Pharmaceuticals Price by Type (2011-2016)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Type (2011-2016)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales by Application (2011-2016)
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application (2011-2016)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Market Share by Application in 2015
Table United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2011-2016)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Sales Growth Rate by Application (2011-2016)
Table GE Healthcare Basic Information List
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table Philips Healthcare Basic Information List
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table Toshiba Basic Information List
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table Hitachi Basic Information List
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table Carestream Basic Information List
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table Esaote Basic Information List
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table Shimadzu Basic Information List
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table TriFoil Imaging Basic Information List
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table Biosensors International Group, Ltd. Basic Information List
Table Biosensors International Group, Ltd. Nuclear Medicine & Radio Pharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biosensors International Group, Ltd. Nuclear Medicine & Radio Pharmaceuticals Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine & Radio Pharmaceuticals
Figure Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Nuclear Medicine & Radio Pharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2015
Table Major Buyers of Nuclear Medicine & Radio Pharmaceuticals
Table Distributors/Traders List
Figure United States Nuclear Medicine & Radio Pharmaceuticals Production and Growth Rate Forecast (2016-2021)
Figure United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Table United States Nuclear Medicine & Radio Pharmaceuticals Production Forecast by Type (2016-2021)
Table United States Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast by Application (2016-2021)